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Abstract
The steroid progesterone, an agonist of acrosome reaction, induces a biphasic [Ca2]i-signal in human sperm comprising an initial
transient [Ca2]i elevation, and a subsequent ramp or plateau. Nifedipine, an inhibitor of voltage-operated Ca2 channels, inhibits
progesterone-induced acrosome reaction in human sperm, but fluorimetric studies have detected no effect of this compound on the
progesterone-induced [Ca2]i signal. We have used single-cell imaging to study the effects of nifedipine on [Ca2]i signalling in human
sperm. Analysis of mean responses from large numbers of cells showed that treatment with nifedipine reduced the duration but not the
amplitude of the progesterone-induced [Ca2]i transient. In control cells, the latency of the transient peak (maximum fluorescence) fell
within the range of 30–105 s. In the presence of nifedipine, very few cells peaked “late” (60 s after application of progesterone). Analysis
of transient responses in control cells revealed characteristic “early” and “late” responses, most cells showing both “early” and “late”
transients, whereas “late” transients were rare and smaller in the presence of nifedipine. Sustained responses showed strong association with
late transients, and occurrence and amplitude of sustained responses were significantly reduced in nifedipine pretreated cells.
These findings are consistent with the occurrence of a discrete, nifedipine-sensitive component of the progesterone-induced [Ca2]i
transient that peaks 1–2 min after exposure to the hormone and is crucial for the induction of the sustained [Ca2]i signal.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
A pivotal event in induction of the acrosome reaction
(AR) by biological agonists is a significant influx of extra-
cellular Ca2, resulting in measurable elevation of [Ca2]i
(Florman et al., 1998; Darszon et al., 1999). However, the
mechanisms underlying this Ca2-influx are poorly under-
stood. By far the best-characterised mammalian system is
induction of AR of mouse spermatozoa by solubilised zona
pellucida (ZP), an important inducer of AR in vivo (Was-
sarman, 1999). In this system, AR is achieved via activation
of (at least) two Ca2 influx pathways. The first event is the
opening of a nonselective cation channel, generating inward
current (and consequent depolarisation) which triggers a
low-voltage activated, T-type voltage operated calcium
channel (VOCC) (Arnoult et al., 1996a,b, 1999). The
[Ca2]i signal from influx through the T-type VOCC is
short-lived (200 ms) but initiates a second, prolonged influx,
probably through store-operated Ca2 channels (O’Toole et
al., 2000; Jungnickel et al., 2001), which activates AR.
Progesterone also acts as an inducer of AR in mammals.
This effect is one of the most-studied, and yet least under-
stood, examples of nongenomic steroid action and is poten-
tially highly important in vivo (Bray et al., 1999; Calogero
et al., 2000; Kirkman-Brown et al., 2002a). Many studies
have demonstrated the efficacy of micromolar concentra-
tions of progesterone (consistent with levels in the human
cumulus; Hartshorne, 1989; Osman et al., 1989) as an in-
ducer of AR in human sperm in vitro. Induction of AR by
progesterone in human sperm, as with ZP in the mouse, is
mediated by a biphasic influx of Ca2. The first phase is a
slow transient, with a typical duration of 2–3 min, which is
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followed by a prolonged plateau or ramp phase (Blackmore
et al., 1990; Baldi et al., 1991; Yang et al., 1994; Plant et al.,
1995; Aitken et al., 1996; Kirkman-Brown et al., 2000).
Single-cell imaging of the response to progesterone re-
vealed a strong linkage between generation of the transient
and sustained responses (Kirkman-Brown et al., 2000). Fur-
ther work has shown that the occurrence of the sustained
response is strongly dependent upon the amplitude of the
preceding [Ca2]i transient, but is resistant to inhibition of
tyrosine kinase activity (Kirkman-Brown et al., 2002b; an
J.C.K-B., unpublished observations). There has been little
work on progesterone-induced signalling in other mammals
but, interestingly, the [Ca2]i response to progesterone in
mouse spermatozoa appears to occur as two types of tran-
sient response which transpire in different populations of
cells (Kobori et al., 2000). Studies on progesterone-induced
AR and generation of diacylglycerol in human sperm have
shown that dihydropyridines, selective blockers of VOCCs
(primarily the L-type), inhibit the action of progesterone
(Shi and Roldan, 1995; O’Toole et al., 1996), suggesting a
vital role for these channels. However, pharmacological
studies on the progesterone-induced [Ca2]i response have
produced little evidence for involvement of VOCCs. Block-
ers of L-type VOCCs are reported to be effective only at
high (nonspecific) doses (Blackmore et al., 1990; Aitken et
al., 1996; Foresta et al., 1993; McLaughlin and Ford, 1994;
Morales et al., 2000). Some fluorimetric studies, which have
employed compounds that show some selectivity for T-type
VOCCs, have detected effects of these compounds on the
amplitude of the [Ca2]i transient. However, the observed
effects have varied greatly between studies, with several
authors observing no effect (Morales et al., 2000; Black-
more et al., 1999; Garcia et al., 1999; Patrat et al., 2000;
Bonaccorsi et al., 2001). Furthermore, the doses needed
have exceeded those normally required for blockade of
T-currents (e.g, Enyeart et al., 1993; Randall and Tsien,
1997; Monteil et al., 2000). The participation of VOCCs in
the response to progesterone, let alone the identity of the
channel(s) involved, is therefore still an open question.
We have developed a method which permits simulta-
neous imaging of [Ca2]i in large numbers of individual
human sperm, permitting detection and detailed analysis of
the [Ca2]i signal that is impossible by fluorimetric or
small-sample imaging methods (Kirkman-Brown et al.,
2000). Using this method, we have investigated the effect of
the dihydropyridine nifedipine on the progesterone-induced
[Ca2]i response in human sperm. We report that the pro-
gesterone-induced [Ca2]i transient is composed of discrete
early and late components. The late component is selec-
tively inhibited by nifedipine and is important for activation
of the sustained [Ca2]i signal. This finding not only pro-
vides a significant advance in our understanding of proges-
terone-induced signalling in sperm, but potentially explains
the striking variability in the reported sensitivity of the
progesterone-induced [Ca2]i transient to VOCC blockade.
Materials and methods
Preparation, capacitation and confocal imaging of sperm
All donors were recruited at the Birmingham Women’s
Hospital (Human Fertilisation and Embryology Authority
Centre No. 0119), in accordance with the Human Fertilisa-
tion and Embryology Authority Code of Practice. Methods
of preparation and imaging were as previously described
(Kirkman-Brown et al., 2000). Briefly, semen was collected
from healthy donors of proven fertility and a direct swim-up
into was performed to select a highly motile population of
sperm (1 ml sEBSS 0.3% BSA underlayered with 0.3 ml
semen; 37°C, 5% CO2). The top 0.7 ml was removed,
pooled, adjusted to 6 million cells/ml and left to capacitate
in 200-l aliquots for 6 h, 37°C, 5% CO2. For imaging, cells
were loaded with Calcium Green 1-AM, introduced into a
purpose built chamber, and adhered to poly-lysine-coated
coverslips. All agonist and antagonist concentrations are
stated at their final concentration. Confocal imaging was
performed on a BioRad MRC600, attached to an inverted
Nikon Diaphot microscope. A BioRad BHS filter set was
employed, using the 488 AR-laser line for excitation.
Confocal data processing and analysis
Data were processed offline by using Lucida software
(Kinetic Imaging Ltd., UK). An ovoid was drawn around
the head of every spermatozoon, and the average intensity
within the head was obtained for all images in the time
series. The image series was then studied repeatedly, and if
a cell moved such that the defined area no longer contained
the entire sperm head, the data from that cell were excluded
from analysis. Other criteria for acceptance or rejection of
data were as applied and described previously (Kirkman-
Brown et al., 2000).
Raw intensity values were imported into Microsoft Excel
and normalised by using the following equation:
R  F  Frest/Frest  100%,
where R is normalised fluorescence intensity, F is fluores-
cence intensity at time t, and Frest is the mean of at least 10
determinations of F taken during the control period.
At each time point the normalised fluorescence intensity
values (R) for each cell were compiled to generate an
overall average normalised head fluorescence (Rtot). The
total series of Rtot was then plotted to give the population
response for that experiment. For each cell, the mean and
95% confidence interval of fluorescent intensity was calcu-
lated for: (1) at least 10 images during the control period [C
 c]; (2) the four images spanning the time for the peak of
the transient response (as assessed from Rtot for that exper-
iment [T  t]); and (3) 12 images collected during the
period from 15 to 18 min after progesterone application (the
sustained response [S  s]). Transient responses were con-
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sidered significant if T  t  C  c. Sustained responses
were considered significant if S  s  C  c.
For investigation of the effect of nifedipine on resting
[Ca2]i, a similar technique was used, except that for each
cell the control intensity [C  c] was compared with fluo-
rescent intensity for the period 5–10 min after application of
the drug [N  n]. For experiments in which the effects of
progesterone were determined after nifedpine treatment,
data were normalised by using the post-nifedipine fluores-
cence [N  n], and analyses of significant transient and
sustained responses were carried out as above.
For investigation of peak latency (delay between proges-
terone application and the peak of the transient response),
the population of cells in which a significant transient oc-
curred (T  t  C  c) was further analysed to determine
the time (during the first 3 min) at which the peak increase
in amplitude occurred. On the basis of this analysis, it
became apparent that nifedipine discriminated between re-
sponses peaking 15–60 s after progesterone (designated
period T1) and 75–120 s after progesterone (designated
period T2). To characterise the behaviour of individual cells
during the two periods, we then calculated, for each cell, the
mean, normalised fluorescence during periods T1 and T2
(T1  t1 and T2  t2, respectively). Individual cells were
then scored for significantly increased fluorescence during
period T1 and/or period T2 [compared with control fluores-
cence for that cell (C  c)]. Mean fluorescence time plots
for each of the categories verified successful sorting of the
data.
To compare the occurrence rate of the various compo-
nents of the progesterone-induced [Ca2]i response in ni-
fedipine-pretreated preparations, mean percentage values
were calculated. Tests of significance were carried out by
using paired or unpaired, two-tailed t tests (selected accord-
ing to the data) or chi-square contingency tables. Percentage
data was arcsine transformed before testing.
Amplitude distributions for components of the [Ca2]i
response were compiled by using the values T, T1, T2, and
S (see above). A distribution (% of total population in each
amplitude class) was compiled for each experiment, and
these were then combined to give mean, normalised values
(SEM).
Assessment of progesterone induced acrosome reaction
After capacitation as described (Kirkman-Brown et al.,
2000), 100-l aliquots of sperm were stimulated with either
3.2 M progesterone, 10 M A23187, or solvent (control;
0.05% DMSO). Nifedipine (1, 10, or 50 M) was added to
the relevant antagonist treatments 10 min before addition of
the agonist. After an incubation of 1 h, slide preparation,
staining, and scoring of acrosomal status were undertaken as
previously described (Kirkman-Brown et al., 2000, 2002b).
Tests of difference between treatment groups were carried
out by using paired t tests (two tailed) on arcsine trans-
formed percentage AR data in Microsoft Excel.
Materials
Calcium Green-1 AM was from Molecular Probes (Cam-
bridge Bioscience, UK); Pentex fraction V Bovine serum
albumin (pH 7) was from Bayer-Pentex (Newbury, Berk-
shire); supplemented Earle’s balanced salt solution (w/o
phenol red) was from Gibco BRL (Paisley, Scotland; special
order No: 041-94189H); and Fluoromount was from BDH
Merck (Poole, Dorset); Nifedipine, Progesterone [4-preg-
nene-3,20-dione], A23187 ionophore [Free Acid], and all
other reagents were analytical or cell-culture grade and were
obtained from Sigma (Poole, Dorset).
Results
Effect of nifedipine on acrosome reaction
Consistent with the findings of previous studies (Shi and
Roldan, 1995; O’Toole et al., 1996), we observed a strong
inhibition, by nifedipine, of progesterone-induced AR, but
no effect on the response to the ionophore A23187. The
effect on progesterone-induced AR was most pronounced at
a dose of 10 M (Fig. 1), so this dose was used for
investigation of the [Ca2]i response, except where stated
otherwise.
Effect of nifedipine on the population response to
progesterone
Upon application of progesterone in control experiments,
fluorescent intensity increased in the postacrosomal region
of most cells (see below). The mean, normalised fluorescent
intensity for all sperm heads in the field of view (Rtot)
Fig. 1. Effects of nifedipine on the progesterone-induced acrosome reaction
(AR). Progesterone (3.14 M) significantly increased AR over that in
controls and in 0.05% DMSO (SC, solvent vehicle for progesterone) (P 	
0.025; n 
 6). This effect was significantly inhibited by pretreatment with
nifedipine at all doses used (* indicates P 	 0.01; n 
 6, paired t test).
A23187 (10 M) increased AR rate to 33%. Nifedipine pretreatment had
no effect (N.S.) on A23187-induced or spontaneous AR rate at any of the
three doses. All bars show mean  SEM (n 
 6).
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increased to a peak within 1–2 min (mean 
 28.0  1.8%;
n 
 23) and then decreased over a similar time course. This
transient response was followed by a sustained elevation,
which began during, or just after, the falling phase of the
transient, and was maintained until the end of the experi-
ment. A similar pattern of response was seen in all experi-
ments for which analysis was carried out, although the
amplitude of the sustained response varied considerably
(Fig. 2a). In preparations pretreated with nifedipine (10 M;
5–10 min), the amplitude of the progesterone-induced tran-
sient increase in Rtot was similar to that in control prepara-
tions (mean 
 25.1  4.2%; n 
 6; NS), but there was a
clear change in the duration. In control experiments, the
[Ca2]i transient in the Rtot trace lasted 3–4 min from onset
to completion (Fig. 2a). In nifedipine-pretreated cells, the
transient response peaked slightly earlier and was com-
pleted within 2 min (Fig. 2b). “Half-duration” of the tran-
sient increase in Rtot (mid point of the rising phase to
midpoint of decay) was 1.97  0.10 min (n 
 23) for
control preparations and 0.95  0.10 min (n 
 6) for
nifedipine-pretreated preparations. (P 	 0.000025). “Amal-
gamated” Rtot plots, composed by pooling all cells from 6
nifedipine-pretreated preparations (1345 cells) and 20 con-
trol preparations (3909 cells) corresponded closely for the
initial rise in fluorescence, but in control preparations, a
large “shoulder” was present. Plotting of the difference
between the two traces revealed a nifedipine-sensitive com-
ponent that activated after approximately 30 s and was
maximal at approximately 2 min (Fig. 2c).
A second marked effect of nifedipine-pretreatment on
Rtot traces was that the sustained [Ca2]i response to pro-
gesterone was greatly reduced or absent. The mean increase
in Rtot for the period 15–17 min after application of pro-
gesterone (representing the sustained response) was greatly
reduced from 14.7  0.8% (n 
 19) to 5.6  3.8% (n 
 6;
P 	 0.025).
Effect of nifedipine on the responses of individual cells to
progesterone
In four experiments, recording was started before appli-
cation of nifedipine. In all of these experiments, a fall in Rtot
of approximately 5% was observed, which occurred over a
period of 1–2 min after exposure to nifedipine (Fig. 2d).
Fluorescent intensity then stabilised or recovered partially
before stabilising. Single cell analysis showed that a signif-
icant fall in fluorescence occurred in 34.5  4.5% of cells,
the amplitude of the effect varying from 10 to 40% (Fig. 2d,
inset). For analysis of subsequent responses to progesterone,
data were normalised by using the stabilised post-nifedipine
fluorescence.
Transient responses
Amplitude of transient responses
In control (non-nifedipine pretreated) experiments, the
distribution of amplitudes for significant, transient progest-
erone-induced responses (T, see Materials and methods)
formed a slightly negatively skewed bell-shape, with a
modal value of 20–30% increase in fluorescence and a tail
of larger responses (Fig. 3a). The distribution of the ampli-
tudes of transient responses in cells pretreated with nifedi-
pine was similar, though the occurrence of responses in the
range 20–40% was noticeably reduced (Fig. 3a).
Proportion of cells generating transient responses
In control preparations, the proportion of cells in which
a significant transient response (T  t  C  c; see
Materials and methods) was detected was 77.2  2.5% (n 

23), a value similar to that reported previously (Kirkman-
Brown et al., 2000). In experiments on cells pretreated with
nifedipine, the frequency of transient responses was 61.7 
6.9% of cells (n 
 6; P 	 0.025; t test).
Time course and latency of transient responses
Rtot traces showed a significant reduction in the duration
of the transient response in nifedipine pretreated prepara-
tions. Attempts to analyse the distribution of the durations
of single cell responses were unsuccessful. The effects of
background noise were such that a high proportion of cells
Fig. 2. Effects of progesterone and 10 M nifedipine on [Ca2]i. (a) Rtot
plots from 23 control experiments showing the response to progesterone
(3.2 M). (b) Rtot plots from 6 experiments showing the response to
progesterone (3.2 M) in preparations previously treated with 10 M
nifedipine. (c) Amalgamated Rtot plots constructed by averaging all cells
from the 6 nifedipine-pretreated preparations and 20 control preparations
[control 
 3909 cells (); nifedipine 
 1345 cells ()]. A third line
(difference) shows the magnitude kinetics of the nifedipine-sensitive com-
ponent. Traces in (a–c) were aligned by the point of progesterone appli-
cation. (d) Effect of 10 M nifedipine on basal [Ca2]i in control (non-
progesterone-treated) cells. Trace shows Rtot from one representative
experiment. Nifedipine (10 M; arrow) caused a reduction in Rtot of
approximately 5%. Single cell analysis showed that this effect was due to
a fall in fluorescence in approximately one-third of the cells. The reduction
in fluorescence in individual cells ranged from 10–40%. Inset shows a
representative group of nifedipine-sensitive cells.
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were “rejected” by the analysis technique. As an alternative,
we examined the effects of nifedipine pretreatment on the
latency of the peak response. For each cell in which a
significant transient occurred, the time of maximum fluo-
rescence during the 3-min period immediately following
application of progesterone was determined. In six nifedi-
pine-pretreated preparations (886 cells), the distribution of
latencies had a clear peak at 30–45 s. Latencies from six
control preparations, carried out during the same period as
the nifedipine experiments (971 cells), had a much broader
distribution of latencies. A peak was still discernible at
approximately 45 s, but there was also a large shoulder
between 75 and 120 s (Fig. 4). Cells which peaked 75 s
after application of progesterone constituted approximately
54% of the population, compared with only 12% in nifed-
ipine-pretreated preparations (Fig. 4; P 	 1061).
Types of single cell transient
Analysis of the effects of nifedipine on Rtot plots and
single cell latencies suggested that nifedipine selectively
inhibits a component of the transient [Ca2]i response that
peaks 75 s after application of progesterone. We further
analysed 24 experiments (6 nifedipine and 18 control) by
sorting cells according to whether they showed significantly
increased fluorescence levels during the early phase (15–60
s; designated T1) and/or the late phase (75–120 s; desig-
nated T2) of the transient [Ca2]i response (see Materials
and methods, and Fig. 4 for illustration). Data from a control
experiment and a nifedipine-pretreated experiment, carried
out on aliquots from the same sample, are illustrated in Fig.
5. Cells that showed significantly increased fluorescence
only during period T1 were detected both in control and
nifedipine-pretreated populations and the kinetics of these
subpopulations were strikingly similar, fluorescence rising
rapidly to peak in 15–30 s and then returning, within a
further 60 s to control levels after a brief “undershoot.” (Fig.
5a). Despite the reduced frequency of transient responses in
nifedipine-pretreated preparations, the occurrence of cells
showing a significant response only during period T1 was
increased from 17.5  2.7% (control) to 33.5  3.0%
(nifedipine-pretreated; P 	 0.005; nonpaired t test; Fig. 6a).
Cells that showed significantly increased fluorescence only
during period T2 were also detected both in control and
nifedipine-pretreated populations, and their kinetics were
again similar. In these cells, fluorescence often rose only
after a 15- to 30-s lag (note point of progesterone addition
on Fig. 5b), reaching peak (typically 10–30% in control
cells) after 75–90 s and then falling slowly (Fig. 5b). The
frequency of occurrence of such cells was reduced after
nifedipine pretreatment (10.3%  2.6% compared with 15.9
 2.1% in controls; Fig. 6a; NS). Cells in which fluores-
cence was significantly increased above control levels dur-
ing both T1 and T2 were present in both sets of data, but the
frequency was lower in the nifedipine-pretreated cells (20.0
 5.2% compared with 44.5  4.5%; P 	 0.01; nonpaired
t test; Fig. 6a). Strikingly, the shape of the responses in cells
which generated a significant increase in fluorescence dur-
ing both T1 and T2 differed markedly in the two data sets,
responses in control cells being broader, with a clear shoul-
der, which was not present in the nifedipine-treated popu-
lation (Fig. 5c).
To compare the amplitudes of the early and late transient
responses, we used the values T1 and T2, the mean, nor-
malised fluorescence during periods T1 and T2 respectively
(see Materials and methods). The distribution of responses
during period T1 was similar in control and nifedipine-
pretreated cells, but the response during period T2 was
clearly different, with both the amplitude and the number of
Fig. 4. Effect of 10 M nifedipine on the latency of transient responses.
Plot shows the distribution of latencies to peak fluorescence in progester-
one-responsive cells. Normalised latency histograms were constructed for
each of 6 nifedipine-pretreated preparations (total of 886 cells) and 6
control preparations carried out during the same period (total of 971 cells).
Points show mean  SEM. For control (, n 
 6), and nifedipine-
pretreated (, n 
 6) cells. T1 and T2 show the time periods used to sort
cells for further analysis.
Fig. 3. Amplitude distributions (in terms of the fluorescence increase) of
significant transients (a) and sustained (15–18 min after progesterone)
responses (b) in control preparations () and in 10 M nifedipine-pre-
treated preparations (). For each experiment, the distribution of ampli-
tudes was normalised by expressing each amplitude class as % of the
population. Curves were then constructed by averaging the distributions for
all control (n 
 23) and nifedipine-pretreated (n 
 6) preparations. Each
point shows mean  SEM.
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responsive cells being lower in the nifedipine-pretreated
preparations (Fig. 6b).
Sustained responses
Amplitude of sustained responses
Significant sustained responses in control preparations
took the form of a plateau or a slowly developing ramp
(Kirkman-Brown et al., 2000). The amplitude of single cell
responses, assessed 15–18 min after the application of pro-
gesterone, was typically a 10–20% increase in fluorescent
intensity over control levels. However, the distribution was
strongly negatively skewed with a tail of larger responses
with amplitudes extending above 100% (Fig. 3b). The dis-
tribution of sustained responses in cells pretreated with
nifedipine also had a modal value of a 10–20% increase in
fluorescence, although the proportion of larger responses
was greatly decreased, with very few responses of greater
than 70% (Fig. 3b).
Occurrence of sustained responses and transient response
type
The overall frequency of significant, sustained responses
was reduced, from 49.9  3.4% of cells in control experi-
ments to 34.1  7.9% in the nifedipine-pretreated prepara-
tions (P 	 0.05). Since generation of sustained [Ca2]i
Fig. 5. Occurrence of early and late components within the progesterone-induced [Ca2]i transient. Using progesterone-induced [Ca2]i responses of control
and 10 M nifedipine-pretreated preparations from the same sample, responsive cells were sorted according to whether fluorescence was significantly above
control levels during period T1 (15–60 s) and/or T2 (75–120 s). Left panels show Rtot traces for cells in control () and nifedipine-pretreated ()
preparations. Responses in nifedipine-treated cells have been scaled-up to facilitate comparison of the kinetics. Arrow indicates time of progesterone addition.
Right panels show representative traces from cells in the control experiment (progesterone addition at t 
 0 min). (a) Cells in which an increase in
fluorescence occurred in period T1 only. (b) Cells in which a significant increase in fluorescence occurred in period T2 only. (c) Cells showing a significant
response during both period; T1 and T2.
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Fig. 6. Effect of 10 M nifedipine on the components of the transient response and their association with sustained responses. (a) Effect of nifedipine on
frequency of occurrence of cells showing significant responses to progesterone during periods T1, T2, both T1 and T2, or neither period. (Left) Mean
percentage in each category (SEM) for 18 control preparations. (Right) Mean  SEM for 6 nifedipine-pretreated preparations. (b) Effect of nifedipine on
the amplitudes of early and late transients in 15 control () and 6 nifedipine-pretreated () preparations. Points show mean  SEM. (Left) Amplitude
distributions of significant early transients. (Right) Amplitude distributions of significant late transients. (c) Association between transient and sustained
responses. Histograms show the proportion of the cells in each of the categories of transient response in which a significant sustained response was also
detected. Left panel shows the mean  SEM for 18 control preparations, right panel shows mean  SEM for 6 nifedipine-pretreated preparations.
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responses upon stimulation with progesterone is linked to
prior generation of a transient response (Kirkman-Brown et
al., 2000), the occurrence of sustained responses in cells
classified into each of the three transient categories (signif-
icant increase in fluorescence during T1, T2, or T1 and T2)
was investigated. Results from the detailed analysis of 18
control preparations (non-progesterone-pretreated) are sum-
marised in Fig. 6c (left panel). Sustained responses were
most common in cells where fluorescence rose during both
periods T1 and T2 (69.0  3.3%), but occurrence in cells
responsive during period T2 only was only slightly lower
(62.1  4.5%, NS). In cells responsive only during period
T1, the occurrence of sustained responses was much lower
(32.9  4.4%; P 	 105 compared with T2 only, paired t)
but still significantly greater than that in cells showing no
transient response (19.9  3.8%, P 	 0.01; paired t). Anal-
ysis of nifedipine-pretreated cells showed a similar pattern
of response, though the absolute frequencies were lower
(Fig. 6c; right panel).
Dose-dependency of the effect of nifedipine
Nifedipine and other dihydropyridine drugs are routinely
used as diagnostic tools to identify participation of L-type
VOCCs in cellular processes. Since effects of these drugs on
L channels are often significant at much lower doses and 10
M is at the top of the useful range for nifedipine (see
discussion), we investigated the effect of 1 M nifedipine
on the duration of the population transient response. Eight
sets of experiments were carried out in which the population
response (Rtot) to progesterone was recorded, in aliquots
from the same sample, under control conditions and in the
presence of both 1 and 10 M nifedipine. Fig. 7a shows
results from one such set of experiments. The responses of
the nifedipine-pretreated preparations have been normalised
to the control response to facilitate comparison. A clear
shoulder was detectable in the control Rtot trace, which was
greatly reduced in the presence of 10 M nifedipine. Ni-
fedipine (1 M) also reduced transient duration, but to a
lesser extent. This effect of 1 M nifedipine was discernible
in six of the eight sets of experiments but was less marked
than the effect of 10 M nifedipine. The mean response to
progesterone, under each of the three conditions, was cal-
culated after first normalising the traces to the amplitude at
30 s after application of progesterone (peak amplitude be-
fore activation of the nifedipine-sensitive component; see
Fig. 2c). The rate of decay of the transient response was
clearly greater at both concentrations of nifedipine, the
effect being more marked at 10 M (Fig. 7b). To compare
the potency of nifedipine at 1 and 10 M, the nifedipine-
sensitive component was obtained (by subtraction of traces)
for each experiment. The kinetics of the nifedipine-sensitive
component were strikingly similar at the two doses, but the
mean amplitude was approximately twice as large with 10
M nifedipine.
Discussion
We have shown previously that progesterone induces a
biphasic [Ca2]i response in human sperm (Kirkman-
Brown et al., 2000). The sustained component of the
response occurs primarily, but not exclusively, in those
cells demonstrating a transient. We have now shown that
pretreatment of cells with 1–10 M nifedipine, which
causes blockade of progesterone-induced AR, modifies
the [Ca2]i response and reveals the existence of two
components within the initial [Ca2]i transient. The late
component is strongly linked to generation of the sus-
tained response.
Fig. 7. Dose-dependence of the effect of nifedipine on the progesterone-
induced [Ca2]i transient. (a) Progesterone-induced responses, in cells
from the same sample, evoked under control conditions () and in the
presence of 1 () and 10 M (Œ) nifedipine. Traces have been nor-
malised to maximum amplitude. A clear shoulder is visible on the
control trace which is inhibited by nifedipine in a dose-dependent
manner. (b) Mean Rtot (n 
 8; mean  SEM) in control and nifedipine-
pretreated preparations. Traces were normalised to amplitude at 30 s
(peak value before activation of the nifedipine-sensitive component; see
Fig. 2). Decay of the transient was consistently faster in the presence of
nifedipine and this effect was clearly dose-dependent. (c) The mean (n

 8; mean  SEM) nifedipine-sensitive component at 1 () and 10
M(Œ) nifedipine. Traces were normalised as in (b) before calculation.
The kinetics of the nifedipine-sensitive component were similar under
the two conditions, but the amplitude of the blocked component was
approximately twice as large in the presence of 10 M nifedipine.
78 J.C. Kirkman-Brown et al. / Developmental Biology 259 (2003) 71–82
Effect of nifedipine on the progesterone-induced [Ca2]i
transient
Pretreatment of cells with 10 M nifedipine (5–10 min)
had no significant effect on the amplitude of the population
transient (Rtot), but markedly reduced its duration. Single
cell analysis showed that this was due to a reduction in the
proportion of single cell responses that peaked relatively
late (75 s) after progesterone challenge. Sorting of cells
according to whether the fluorescence was elevated signif-
icantly during the early (15–60 s) and/or late (75–120 s)
parts of the [Ca2]i transient revealed two types of response
that were strikingly different. The early responses were brief
(completion within 60–90 s followed by an undershoot; Fig.
5a) and nifedipine-resistant, whereas the late responses ac-
tivated after a longer latency (15–30 s) decayed more slowly
and were both smaller and less common in nifedipine-
pretreated preparations (Figs. 5 and 6). The kinetics of late
responses resemble those of the nifedipine-sensitive com-
ponent of Rtot (compare Figs. 2c and 5b). We conclude that
the progesterone-induced [Ca2]i transient includes two
components, one of which is inhibited by 10 M nifedipine
(transient 2) and the other is not (transient 1). Interestingly,
the occurrence of two types of progesterone-induced
[Ca2]i responses with different durations (60–80 s and
180 s) has been reported in mouse sperm. The longer
lasting type of response, which required high doses of pro-
gesterone for induction (	30% of cells were responsive at
40 M) was sensitive to the VOCC blocker pimozide at 1
M (Kobori et al., 2000).
Effect of nifedipine on the progesterone-induced sustained
[Ca2]i response
Besides modifying the transient response, 10 M nifed-
ipine had a marked effect on the sustained [Ca2]i signal.
We have previously shown that occurrence of the sustained
response in an individual cell is closely linked to the occur-
rence and amplitude of the transient response (Kirkman-
Brown et al., 2000). It might, therefore, be anticipated that
the nifedipine-induced reduction in the frequency of occur-
rence of transient responses [T; scored irrespective of the
contributing component(s)] would be accompanied by an
equivalent effect on the frequency of occurrence of sus-
tained responses. In fact, the nifedipine-induced reduction
in the frequency of occurrence of sustained responses
(30%) was proportionately greater than the effect on tran-
sient responses (	20%). Furthermore, though the modal
amplitude of sustained responses was unchanged
(10–20%), nifedipine-pretreatment prevented the occur-
rence of the large (70%) sustained responses seen in a
proportion of control cells (Fig. 3b). Both of these obser-
vations are consistent with a reduction of mean amplitude in
nifedipine-treated cells, coupled with an inability to detect
very small (	10%) responses that may not significantly
exceed the noise. The data summarised in Fig. 6c suggest
that selective inhibition of transient 2 by nifedipine is of
particular importance in this respect, transient 2 being sig-
nificantly more effective as an “inducer” of the sustained
response than transient 1. It is therefore possible that block-
ade of the nifedipine-sensitive channels that underlie tran-
sient 2 is responsible for the strong inhibition of sustained
[Ca2]i responses that occur in nifedipine-treated prepara-
tions. An alternative explanation is that the sustained
[Ca2]i response, as well as transient 2, is carried by a
nifedipine-sensitive channel. If the action of nifedipine is
through blockade of VOCCs (see below), then this is un-
likely since these channels (including L-type channels;
which seem to be present in mature sperm; Kirkman-Brown
et al., 2002a; Benoff, 1998) normally inactivate within a few
seconds. However, it is worthy of note that: (1) after sorting
cells according to the nature of the transient response, ni-
fedipine reduced the proportion of cells generating sus-
tained responses in all categories, and (2) treatment of
hamster sperm with 10 M nifedipine was observed to
inhibit selectively the prolonged component of the ZP-
induced [Ca2]i response (Shirakawa and Miyazaki, 1999).
A direct effect of nifedipine on channels participating in the
progesterone-induced sustained influx therefore remains a
possibility.
The nifedipine-sensitive component of the transient
Progesterone causes depolarisation of the human sperm
membrane potential (Foresta et al., 1993; Patrat et al.,
2002), consistent with activation of voltage-sensitive Ca2
influx pathways. Our data show that the progesterone-in-
duced [Ca2]i transient is complex, involving a late nifed-
ipine (1–10 M)-sensitive component. Interestingly, depo-
larisation of human spermatozoa with 60 mM K causes an
influx of Ca2 (consistent with activation of VOCCs), but
this effect is resistant to diltiazem (10 M) and nifedipine
(up to 50 M) and is only partially blocked by 10 M
mibefradil and 50 M Ni2. It thus appears that the dihy-
dropyridine-sensitive component of progesterone-induced
Ca2 influx is not identical to the influx induced by K-
mediated depolarisation. One interpretation is that the effect
of nifedipine on progesterone-induced Ca2 influx does not
involve VOCCs. Though this remains a possibility, we
consider it more likely that progesterone activates a specific
population of nifedipine-sensitive VOCCs through a com-
bination of depolarisation and another agonist-induced pro-
cess. Such a bifurcating pathway has been proposed for
activation of VOCCs in mouse spermatozoa by zona pellu-
cida (Arnoult et al., 1996a; Darszon et al., 1999).
Doses of 1–10 M nifedipine (as employed here) are
commonly used to assess the involvement of L-type VOCCs
in cellular activities (Cohen, 2001; Godukhin et al., 2002;
Piacentino et al., 2002; Kawanabe et al., 2002; Park et al.,
2002; Waitkus-Edwards et al., 2002; Nakano et al., 2002;
Hashitani et al., 2002; Staras et al., 2002). In human sper-
matozoa, 1 M nifedipine was approximately half as effec-
tive as 10 M in blocking the progesterone-induced AR
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(Fig. 1) and was half as effective in inhibiting the progest-
erone-induced late transient (Fig. 7). Since the relationship
between Calcium Green 1 fluorescence and [Ca2] is non-
linear, the effect of 1 M nifedipine on Ca2 influx is, in
fact, considerably more than half as great as that at 10 M.
If 10 M is a saturating or near-saturating dose, then the
IC50 for the effect of nifedipine is probably in the near-M
or low-M range. In comparison, blockade of contractile
activity in heart and vascular tissues occurs at nM concen-
trations (Sun and Triggle, 1995). However, sensitivity to
blockade by dihydropyridines of L channels (or L-channel-
dependent biological responses) can vary widely, even
among cardiac and vascular tissues (Sun and Triggle 1995;
Sarsero et al., 1998). This phenomenon reflects, at least in
part, the expression of differentially spliced isoforms in area
IS6 of the 1 subunit (Welling et al., 1997), an effect that
has recently been demonstrated in recombinant 1C subunits
(Morel et al., 1998). IS6 is one of the regions at which
human testis 1C shows alternative splicing (Goodwin et al.,
1999). 1D mRNA (L-type) has been detected in mouse
(Lievano et al., 1996) and human (E.L. Punt, unpublished
observations). testis, and 1D subunits have recently been
reported in mouse round spermatids (Son et al., 2002), but
some researchers have failed to detect 1D in spermatozoa
(Jagannathan et al., 2002b). Doses of 1–10 M are required
for blockade of recombinant 1D channels (Bell et al.,
2001). In addition to the effects of alternative splicing, the
efficacy of L channel blockade by dihydropyridines is
strongly voltage-dependent, the drugs being more effective
at depolarised membrane potentials (Sanguinetti and Kass,
1984). It is believed that the sperm membrane hyperpo-
larises during capacitation to release T-type VOCCs from
inactivation (Arnoult et al., 1999). We conclude that the
efficacy of nifedipine in inhibiting the response to proges-
terone is not inconsistent with action on an L-type VOCC.
Another possibility is that nifedipine exerts its effect
through blockade of T-type channels. In previous studies,
compounds that are recognised blockers of T-channels (e.g.,
pimozide and mibefradil) have been reported by some au-
thors to affect the progesterone-induced [Ca2]i response in
human spermatozoa (e.g., Morales et al., 2000; Garcia et al.,
1999; Patrat et al., 2000). Interpretation of these data is
difficult since these drugs can have effects on high voltage-
activated channels at the doses at which they are normally
used (Gould et al., 1983; Enyeart et al., 1990; Bezprozvanny
and Tsien, 1995; Ito et al., 1996; Protas and Robinson,
2000; Wu et al., 2000). Conversely, though dihydropyri-
dines such as nifedipine are selective for VOCCs and par-
ticularly effective as blockers of L-type channels, these
compounds do not discriminate absolutely between L and
T-type currents. Though some T-currents show little block-
ade by 10 M nifedipine (e.g., Gu et al., 1999; Lacinova et
al., 2000), the low voltage-activated current of mouse sper-
matocytes is extremely sensitive with an IC50 close to 1 M
(Santi et al., 1996; Arnoult et al., 1998), similar to that
estimated for nifedipine in this study. On balance, though
the pharmacological data permit no firm conclusion, we
consider the kinetics of the nifedipine-sensitive component
(transient 2) are such that, if the effect of nifedipine reflects
inhibition of a VOCC, it is more likely that it is exerted on
an L-type than a T-type channel. Detailed interpretation of
the effects of VOCC-blocking drugs on [Ca2]i signalling
in human sperm may ultimately require parallel dose-effect
studies on the actions of these compounds on [Ca2]i sig-
nals in spermatozoa and channels in patch clamped cells. As
T-type channel currents, which have been characterised in
mouse spermatogenic cells (Arnoult et al., 1998) can be
detected only rarely in immature human male germ cells
(and no other VOCC currents were detected) patch clamp-
ing of mature spermatozoa or the use of expressed recom-
binant channels may be required (Jagannathan et al.,
2002a,b).
In summary, we describe here, for the first time, the
occurrence of two, discrete components of the progesterone-
induced [Ca2]i signal in human spermatozoa, recognisable
at the level of individual cells. The later of these (transient
2) is sensitive to the dihydropyridine nifedipine (1–10 M)
and is apparently the more important in activation of the
sustained [Ca2]i signal and acrosome reaction. These data
at last explain the efficacy of dihydropyrinies as inhibitors
of AR and their apparent contraceptive effect (Hershlag et
al., 1995). A crucial next step is characterisation of the early
transient (transient 1) in dihydropyridine-treated cells in
which it is pharmacologically isolated.
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